Journal of Pain Management & Medicine

Department of Pharmaceuticals Research, Pure Green Pharmaceuticals, West Bloomfield, 48323, USA

Publications

• Case Report   
  Low Dose Cannabidiol for the Treatment of Mild to Moderate Musculoskeletal Pain
  Author(s): Matthew K Caloura*, Debra Kimless, Susan Lewis and Stephen Goldner
  
  Sixteen healthy, cannabis and cannabidiol (CBD) naïve patients with mild to moderate musculoskeletal pain took a single dose of 5 mg CBD sublingual tablet. Patients were using other-the-counter (OTC) medications to treat various manifestations of musculoskeletal pain, including neck, back, muscle aches, and arthritis. The average self-reported pain scale score (NPRS), measured on a scale of 0-10, was 5.13 prior to taking the CBD tablet. After tablet administration, the patients self-reported their pain scale score over a 2-hour period. All patients reported pain reduction within 20 minutes after taking the tablet and continued over the 2-hour period where the average reported pain was reduced by 20-fold (NPRS 5.13 to 0.25) and was statistically significant (p<0.001). No patients reported any adverse effects and characterized the experience as positive. Th.. View more»
  

  DOI: 10.35248/2684-1320.21.7.156

  Abstract HTML PDF